53 episodes

MediCom Oncology Clinical Pearl Podcasts provide practical, evidence-based recommendations on real-world issues in the clinical setting, in under three minutes. Leading experts and academic faculty from top research and practice institutions provide guidance to community-based healthcare providers, including oncologists, pharmacists and nurses. Podcasts are brought to you by MediCom Worldwide, Inc., an accredited, independent medical education company.

Podcasts are intended for licensed adult healthcare professionals (HCPs). HCPs should exercise professional judgment in evaluating content, and confirm information before implementing treatment or practice-related changes. Podcasts do not provide medical advice to patients.

MediCom Oncology Clinical Pearls Podcasts MediCom Oncology

    • Science
    • 5.0, 1 Rating

MediCom Oncology Clinical Pearl Podcasts provide practical, evidence-based recommendations on real-world issues in the clinical setting, in under three minutes. Leading experts and academic faculty from top research and practice institutions provide guidance to community-based healthcare providers, including oncologists, pharmacists and nurses. Podcasts are brought to you by MediCom Worldwide, Inc., an accredited, independent medical education company.

Podcasts are intended for licensed adult healthcare professionals (HCPs). HCPs should exercise professional judgment in evaluating content, and confirm information before implementing treatment or practice-related changes. Podcasts do not provide medical advice to patients.

    Third-generation FLT3 inhibitors in clinical development

    Third-generation FLT3 inhibitors in clinical development

    Dr. Perl provides a brief summary of what is on the horizon for FLT3 inhibitors in AML.

    • 2 min
    CAR T case study in acute myeloid leukemia

    CAR T case study in acute myeloid leukemia

    Dr. Sallman describes a patient case demonstrating promise in the further study and potential use of CAR T-cell therapy for patients with AML.

    • 5 min
    Key considerations when prescribing midostaurin with a strong CYP3A4 inhibi

    Key considerations when prescribing midostaurin with a strong CYP3A4 inhibi

    Dr. Perl gives guidance on providing optimal patient therapy when prescribing midostaurin with a strong CYP3A4 inhibitor.

    • 2 min
    How to proceed with a patient who presents with idiopathic cytopenia of undetermined significance

    How to proceed with a patient who presents with idiopathic cytopenia of undetermined significance

    In this audio activity, Dr. Goldberg describes his approach to patients with idiopathic or clonal cytopenias of undetermined significance (ICUS and CCUS).

    • 3 min
    When to consider iron chelation therapy for a transplant-eligible patient

    When to consider iron chelation therapy for a transplant-eligible patient

    Listen as Dr. Goldberg explains his approach to iron chelation therapy in patients who are, or may be within the next 5-10 years, eligible for transplant.

    • 3 min
    53-year-old woman presenting with severe fatigue and bruising

    53-year-old woman presenting with severe fatigue and bruising

    Hematopathologist Dr. Khoury presents a case snapshot showing the complexities of diagnosing AML, describing the importance of morphology, flow cytometry, cytogenetics, and molecular diagnostics.

    • 3 min

Customer Reviews

5.0 out of 5
1 Rating

1 Rating

Top Podcasts In Science

Listeners Also Subscribed To